Companies Analyzing the Price-to-Earnings Ratio of Adaptimmune Therapeutics Plc ADR (ADAP) The 36-month beta value for ADAP is also noteworthy at 2.23. There are mixed opinions on the stock, with 3 analysts rating it as a
Hot Stocks Adaptimmune Therapeutics Plc ADR (ADAP) Stock: A Closer Look at the Analyst Ratings Additionally, the 36-month beta value for ADAP is 2.25. There are mixed opinions on the stock, with 3 analysts rating it as a “buy,” 2
Trending Adaptimmune Therapeutics Plc ADR’s (ADAP) Stock: A Week-by-Week Analysis The stock of Adaptimmune Therapeutics Plc ADR (ADAP) has gone up by 0.79% for the week, with a 5.06% rise in the past month and